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Sprint Fidelis Lead Fractures in Patients With Cardiac Resynchronization Therapy Devices: Insight From the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) Study
Summary: In this multicenter, randomized trial, Sprint Fidelis fractures were found to occur more frequently in the group that received both an implantable cardioverter-defibrillator and cardiac resynchronization therapy than in the group that received only an implantable cardioverter-defibrillator. This is the first study to have adjudicated lead fracture in a blinded fashion, with systematic follow-up in a clinical trial. Our main findings were an overall rate of lead fracture of 1.65%, with a hazard ratio of 2.42 for patients with both an implantable cardioverter-defibrillator and cardiac resynchronization therapy. The only predictor of lead fracture in this population was having undergone both implantation of an implantable cardioverter-defibrillator and cardiac resynchronization therapy. The Fidelis lead issue has provided invaluable information on lead behavior and risks for fracture. The Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) study has been able to contribute further information on how cardiac resynchronization therapy influences the risk of fracture related to this lead. The increased risk of fracture in cardiac resynchronization therapy patients should be taken into account when such patients appear for generator change, where the risk for fracture is higher than in a standard implantable cardioverter-defibrillator. Prophylactic revision of the lead in such cases needs to be considered carefully in terms of risks and benefits of this intervention.
Conclusions:
In this analysis of the RAFT study, patients with an implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy were found to have a significantly higher fracture rate than patients with an ICD. This finding needs to be considered when these patients are assessed for possible lead revision at the time of an elective generator replacement. 1 
Mechanism of Loss of Kv11.1 K+ Current in Mutant T421M-Kv11.1-Expressing Rat Ventricular Myocytes: Interaction of Trafficking and Gating
Summary: Congenital long QT syndrome type 2 is an inherited arrhythmia disorder characterized by prolonged QT intervals on ECGs in the absence of structural heart disease. Long QT syndrome type 2 is caused by mutations in the KCNH2 (hERG) gene encoding Kv11.1 potassium channels, resulting in reduced repolarizing current (IKr). Long QT syndrome type 2 mutations affect channel function mainly by defective channel protein trafficking to cell membrane or abnormal channel gating. We studied the T421M-Kv11.1 missense mutation identified in a multigenerational long QT syndrome type 2 family with variable penetrance of the mutation phenotype. T421M is localized in the Kv11.1 S1 transmembrane domain. We investigated the disease mechanism by heterologous adenoviral expression of mutant and WT channels in adult rat ventricular myocytes. Compared with wild-type channels, the T421M-Kv11.1 homotetrameric channels have both altered protein trafficking and channel gating properties. When coexpressed, heterotetrameric channels remained trafficking deficient but had wild-type-like gating properties. Thus, the gating properties of heterotetrameric channels do not follow a dominant-negative pattern, whereas the trafficking abnormality does. The lack of a severe dominant-negative effect of mutant α-subunits on the cellular electrophysiology may result in heterotetrameric channels that potentially result in a milder clinical phenotype. Finally, because the proband experienced cardiac arrest triggered by auditory startle, we studied β-adrenergic stimulation of wild-type-Kv11.1 and T421M-Kv11.1 channels in adult rat ventricular myocytes. Wildtype-Kv11.1 and T421M-Kv11.1 channels responded to isoproterenol by increasing current amplitude, suggesting that Kv11.1 channels could be a direct substrate for β-blocker therapy. Our findings may provide new mechanistic insights into disease phenotype and severity.
Conclusions:
The T421M-Kv11.1 mutation caused a loss of IKv11.1 through interactions of abnormal protein trafficking and channel gating. Furthermore, for coexpressed WT+T421M-Kv11.1 channels, different dominant-negative interactions govern protein trafficking and ion channel gating, and these are likely to be reflected in the clinical phenotype. Our results also show that WT and mutant Kv11.1 channels responded to β-adrenergic stimulation. 2 
Fetal Heart Rate Predictors of Long QT Syndrome
Summary: Long QT syndrome (LQTS) may be as common as 1/2500 individuals, yet fewer than 100 cases have been recognized during fetal life. Fetal torsades de pointes and 2° AV block are easily attributed to LQTS. However, these complex arrhythmias are present in only 25% of fetal LQTS; the majority of LQTS fetuses have asymptomatic bradycardia that may not be recognized as an LQTS marker due to its subtle features. The standard obstetric definition of bradycardia is fetal heart rate (FHR) ≤ 110 bpm. To improve recognition of perinatal LQTS we evaluated the FHR/gestational age (GA) relationship of fetal LQTS mutations versus a normal control group. We found GA dependent FHR predictors of LQTS; for example, when compared to a FHR of 110 bpm at any GA, a FHR ≤3rd percentile for GA improves ascertainment of LQTS subjects from 15 to 85%. Fetuses with the lowest FHR tended to have de novo and genetically elusive LQTS mutations, and in addition to bradycardia, also manifested complex LQTS rhythms. Identification of LQTS in the fetus with a heart rate of <3rd also led to diagnosis of LQTS in unsuspecting family members. Thus, postnatal evaluation of individuals with a Summary: Despite anticoagulation, stroke remains a complication of atrial fibrillation. Several randomized controlled trials have compared rate and rhythm control approaches in patients with atrial fibrillation and demonstrated a similar impact on mortality, but most trials had inadequate sample size to assess their relative effect on stroke outcome. In the current observational study, we compared the rates of stroke/ transient ischemic attack in patients treated with rhythm (n=16 325) or rate (n=41 193) control strategies in a large population-based cohort of patients with recently diagnosed atrial fibrillation. Crude stroke/ transient ischemic attack incidence in the rhythm control group was 1.74 per 100 person-years in comparison with 2.49 in the rate control group (P<0.001). Although at baseline, patients receiving rhythm control therapy had fewer risk factors for stroke in comparison with patients receiving rate control therapy, the association between rhythm control treatment and lower stroke rates remained after multivariate analysis (adjusted hazard ratio, 0.80; 95% confidence interval, 0.74, 0.87) and propensity score analysis (adjusted hazard ratio, 0.77; 95% confidence interval, 0.68, 0.87), which balanced patients' characteristics between groups. Once stratified by CHADS2 (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and previous stroke or transient ischemic attack) score, the rhythm control group had a lower stroke risk than the rate control group only for patients with high-and moderate-risk CHADS2 scores. The results of this study provide additional information to guide clinicians' choice of treatment strategy by considering the outcome of stroke. This study may stimulate future large randomized trials comparing the effectiveness of rhythm versus rate control strategies on the risk of stroke and emphasizes the need for the development of new therapies for atrial fibrillation.
Conclusions:
In comparison with rate control therapy, the use of rhythm control therapy was associated with lower rates of stroke/ transient ischemic attack among patients with atrial fibrillation, in particular, among those with moderate and high risk of stroke. 4 
Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Summary: The clinical efficacy of alcohol septal ablation for obstructive hypertrophic cardiomyopathy has been demonstrated, but the effects of the procedure on late survival remain uncertain. We examined 177 patients (mean age, 64 years; 68% women) who underwent septal ablation at our institution. The survival of patients who had septal ablation was no different than the expected survival for a comparable general population (8-year estimate, 79%), and similar to that of age-and sex-matched patients who underwent isolated surgical myectomy. The annual incidence of sudden cardiac death was ≈1.3%. This study demonstrates that favorable long-term survival can be achieved in carefully selected patients who undergo septal ablation by experienced operators in a tertiary referral hypertrophic cardiomyopathy center.
Conclusions:
In this nonrandomized study of carefully selected patients undergoing septal ablation by experienced operators in a tertiary referral hypertrophic cardiomyopathy center, long-term survival was favorable and similar to that of an age-and sex-matched general population, and to patients undergoing surgical myectomy, as well, without an increased risk of sudden cardiac death.
5

Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature
Summary: Novel oral anticoagulants, including direct thrombin inhibitors and factor Xa inhibitors, have been proposed as alternatives to vitamin K antagonists for the prevention of stroke and systemic embolism in patients with atrial fibrillation. We conducted a systematic review and a meta-analysis of published and unpublished phase II and III randomized, controlled trials comparing the novel oral anticoagulants with the vitamin K antagonists in patients with atrial fibrillation. We retrieved 12 studies (3 administering dabigatran, 4 administering rivaroxaban, 2 administering apixaban, and 3 administering edoxaban) enrolling >50 000 patients. We found that the novel oral anticoagulants significantly reduced overall mortality, cardiovascular mortality, and stroke or systemic embolism. Furthermore, these drugs showed a trend toward reduced major bleeding, with a significant reduction of intracranial hemorrhage. The novel oral anticoagulants may potentially address some of the limitations of vitamin K antagonists because they have fewer food and drug interactions and a more predictable anticoagulant effect, thus allowing fixed-dose regimens without the need for routine laboratory monitoring. Our meta-analysis also provided robust evidence on the overall clinical benefit of the novel oral anticoagulants, suggesting their costeffectiveness in the real-life healthcare systems.
Conclusions: Novel oral anticoagulants are associated with an overall clinical benefit compared with vitamin K antagonists. Additional research is required to confirm these findings outside the context of randomized trials. 
Transient Receptor Potential Canonical-3 Channel-Dependent Fibroblast Regulation in Atrial Fibrillation
Summary: Atrial fibrillation (AF) is the most common clinical arrhythmia, and its therapy is problematic. There is a need for novel treatment interventions, and mechanistic insights may be helpful in developing such new therapies. Here, we examined the role of a new type of ion channel, the nonselective cation channel TRPC3 (transient receptor potential canonical-3), in AF. TRPC3 can carry a number of ions but may be particularly important as an entry pathway for calcium into nonexcitable cells such as fibroblasts. Tissue fibrosis is produced by an overproduction of extracellular matrix proteins by fibroblasts and is believed to be important in AF. In addition, fibroblasts may contribute to AF via electric interactions with excitable heart cells (cardiomyocytes). We first found that cardiac fibroblasts expressed functional TRPC3 channels, and TRPC3-mediated calcium entry into fibroblasts activated a signaling molecule (extracellular signal-regulated kinase) that induced fibroblast proliferation and differentiation into activated myofibroblasts. We also noted that TRPC3 expression was upregulated in AF patients and 2 experimental AF models. We then studied the role of TRPC3 in atrial remodeling of dogs kept in AF for 7 days by atrial tachypacing. We found that AF increased TRPC3 protein expression and current, although it activated fibroblasts, and that blocking TRPC3 suppressed fibroblast activation and the AF-promoting remodeling caused by AF. We also identified the molecular pathway that leads to TRPC3 upregulation in AF: Downregulation of a TRPC3-suppressing microRNA, miR-26, caused by AF-induced nuclear translocation/regulation by nuclear factor of activated T-lymphocytes (NFAT) in fibroblasts. This work provides novel insights into molecular mechanisms underlying AF, as well as potential new anti-AF targets. Summary: Substrate mapping of ventricular tachycardia typically uses indirect measures of identifying myocardial scar, including electroanatomic voltage mapping and intracardiac echocardiography. We describe a novel catheter capable of direct endocardial visualization during mapping and irrigated radiofrequency ablation. The catheter contains a small fiberscope capable of directly visualizing the endocardial surface through a clear hood on the catheter tip with a 6.8-mm field of view. Saline is constantly flushed through the catheter to clear blood from the hood and allow visualization of the endocardial surface. Electrograms can be recorded from 4 orthogonal electrodes on the catheter tip; irrigated radiofrequency ablation can be performed via an electrode proximal to the catheter tip that heats the saline irrigant. We tested whether this catheter could visually differentiate among dense scar, border zone, and normal myocardium in an ovine model of chronic myocardial infarction. With the use of image processing techniques, the visual whiteness in the field of view was quantified and correlated well with electrogram measures of scar. Irrigated ablation lesions were delivered and could be observed in both healthy myocardium and myocardial scar. This approach offers a new paradigm in catheter ablation. Advantages include confirmation of catheter contact with the endocardium, direct visualization of anatomic structures such as the papillary muscles and myocardial scar, improved efficacy and safety of catheter ablation through visualization of lesion formation, and the ability to visually confirm contiguity of lesions delivered in a linear fashion during catheter ablation. Malignant ventricular arrhythmias such as ventricular tachycardia can develop in otherwise healthy individuals carrying proarrhythmic mutations and in patients affected by cardiomyopathies such as ischemic heart disease and heart failure. Although the administration of classic antiarrhythmic drugs (ie, β-blockers and amiodarone) and the implantation of cardiac defibrillators constitute a cornerstone of current patient management, only a better understanding of the molecular circuitries underlying ventricular arrhythmogenesis will pave our way toward new frontiers in sudden cardiac death prevention. For this purpose, experimental dissection of the molecular pathways that fine-tune both second messenger signaling and excitation-contraction coupling in cardiomyocytes is paramount. In the present work, using genetically modified mice, we have uncovered that the enzyme phosphoinositide 3-kinase γ (PI3Kγ) is required to maintain a physiological function of important myocardial phosphodiesterases such as phosphodiesterase 3A, 4A, and 4B. Biochemical and functional data indicate that PI3Kγ constitutes a necessary scaffold for these phosphodiesterases because the loss of PI3Kγ leads to abnormal cAMP accumulation, to inappropriate activation of cAMP targets such as L-type calcium channel, and to spontaneous calcium release events in cardiomyocytes. Although in normal hearts the loss of PI3Kγ leads to benign premature ventricular beats on β-adrenergic stimulation, cardiac pressure overload precipitates the development of ventricular tachycardia and rapidly results in substantial mortality. These findings indicate that the β-adrenergic/PI3Kγ/phosphodiesterase signaling hub may constitute a promising molecular target for the development of novel antiarrhythmic therapeutic interventions.
Conclusions
Conclusions: PI3Kγ coordinates the coincident signaling of the major cardiac PDE3 and PDE4 isoforms, thus orchestrating a feedback loop that prevents calcium-dependent ventricular arrhythmia. 
Ascending-Ramp Biphasic Waveform Has a Lower Defibrillation Threshold and Releases Less Troponin I Than a Truncated Exponential Biphasic Waveform
Summary: We demonstrated that an ascending-ramp biphasic shock has a significantly lower defibrillation threshold and causes release of less than half as much troponin I as a truncated exponential biphasic shock at almost the same energy and at a higher peak voltage than the truncated exponential biphasic shock. This result indicates that the shape of the shock waveform, in addition to the peak voltage and energy of the waveform, affects cardiac damage caused by a shock. The results of this study suggest that, in addition to optimizing the shock waveform to decrease the defibrillation threshold, the shock waveform should be optimized to decrease the damage caused by defibrillation. Therefore, it is theoretically possible that the waveform with the lowest defibrillation threshold may not necessarily cause the least damage. Serendipitously, an ascending-ramp first-phase biphasic waveform has both a lower defibrillation threshold energy and a shape that causes less damage than the truncated exponential biphasic waveform. Further investigation is needed to determine whether an ascending ramp biphasic waveform will cause less shock damage to human hearts.
Conclusions:
The ascending ramp has a significantly lower defibrillation threshold and at ≈30 J causes 58% less troponin I release than the truncated exponential biphasic shock. Therefore, the shock waveform affects both the defibrillation threshold and the amount of cardiac damage.
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Implantable Cardioverter-Defibrillators Have Reduced the Incidence of Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Lethal Arrhythmias
Summary: The proportion and incidence of patients with out-ofhospital cardiac arrest (OHCA) that are found in ventricular fibrillation (VF) decreased over the last decades. It used to be well over 70% (incidence, 0.3-0.7/1000 inhabitants) and decreased to 25% to 50% (incidence, 0.1-0.3/1000 inhabitants) in a period of 15 to 20 years. The reason for this worldwide decline in VF is not clear. Possible explanations include a changing morbidity pattern from ischemic heart disease with more chronic heart failure, increased use of β-adrenergic receptor blocking drugs, and later arrival on scene by emergency medical services. We investigated the community impact of implantable cardioverter-defibrillators (ICDs) for primary and secondary prevention by comparing OHCA in the periods 1995 to 1997 when ICD therapy hardly existed to 2005 to 2008 in the Dutch province of North Holland. We took into consideration that if no ICD had been placed, resuscitation for OHCA would have occurred only in part of the patients who received an appropriate ICD shock. The incidence (per 100 000 inhabitants per year) of VF OHCA decreased March 26, 2013 from 21.1 to 17.4, and non-VF OHCA increased from 12.2 to 19.4, corresponding with a decline of VF OHCA from 63% to 47%. ICD shocks avoided 1.2 VF OHCA per 100 000 inhabitants per year. Thus, successful ICD shocks explained 33% of the decline in VF OHCA. In a sensitivity analysis, the explained decline ranged from 16% to 63%. Part of the decreased proportion of VF OHCA of all OHCA was explained by an even larger (and unexplained) increase in non-VF OHCA. Nevertheless, other factors must play at least an equal role in the explanation for the observed decline in VF OHCA.
Conclusions:
The incidence of VF OHCA decreased over the last 10 years in North Holland. ICD therapy explained a decrease of 1.2/100 000 inhabitants per year, corresponding with 33% of the observed decline in VF OHCA.
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A Comprehensive Evaluation of Rhythm Monitoring Strategies for the Detection of Atrial Fibrillation Recurrence: Insights From 647 Continuously Monitored Patients and Implications for Monitoring After Therapeutic Interventions
Summary: Patient follow-up with either short-or long-duration intermittent rhythm monitoring is significantly inferior to that with continuous rhythm monitoring for the detection of atrial fibrillation (AF) recurrence. Intermittent rhythm monitoring strategies fail to identify AF recurrence in a great proportion of patients at risk. Even with feasible, aggressive intermittent monitoring strategies (such as quarterly 24-hour Holter monitoring), AF recurrence will not be identified in a significant proportion of patients. Because of the low sensitivity of intermittent rhythm monitoring, the results of pharmacological or invasive interventions for AF when evaluated with intermittent monitoring should be considered with caution because chance has an immeasurable effect on the detection of AF recurrence, and thus a great proportion of patients will be misclassified, AF recurrence will be underdiagnosed, and therapeutic success will be overestimated. Novel quantitative and temporal AF characteristics (AF burden, AF density) play a major role in AF recurrence detection with the use of intermittent monitoring strategies and may influence clinical parameters and outcomes in AF patients. For accurate patient management, as well as for the scientific, evidence-based evaluation of AF treatments, continuous rhythm monitoring should be strongly recommended.
Conclusions: Intermittent rhythm monitoring (IRM) follow-up is significantly inferior to continuous rhythm monitoring (CM). IRM strategies will not identify AF recurrence in a great proportion of patients at risk. Temporal AF characteristics play a significant role in AF recurrence detection with the use of IRM. For the scientific, evidence-based evaluation of AF treatments, CM should be strongly recommended. Prospective studies are required to evaluate whether CM to guide clinical management can also improve patient outcomes. Summary: In the United States, ≈300 000 pacemakers are implanted annually, 5% of which result in serious complications requiring surgical revision or other invasive procedures. In addition, electronic pacemakers have limitations such as an inadequate autonomic response, limited battery life, and restrictions with regard to stable lead positioning. These issues may be dealt with in part by the development of biological pacemakers. Within the framework of biological pacing, the AC1-based approach shows potential because it generates highly stable pacemaker function at beating rates of ≈60 bpm and incorporates sensitivity to sympathetic and parasympathetic input. Two important hurdles on the road to clinical application include the demonstration of stable long-term function and the demonstration of safety with regard to both potential proarrhythmia and toxicity. The continued development of electronic pacemakers may obviate the need for biological alternatives, but regardless of whether biological pacemakers find clinical application, their development will continue to increase our understanding of pacemaker function and of cardiac gene therapy.
Conclusions: AC1 or HCN2/AC1 overexpression in left bundle branches provides highly efficient biological pacing and greater sensitivity to autonomic modulation than HCN2 alone. Summary: Catecholaminergic polymorphic ventricular tachycardia is a congenital arrhythmogenic disease linked to β-adrenergic-induced ventricular arrhythmias that has a high mortality in children and young adults when untreated. As common features of the catecholaminergic polymorphic ventricular tachycardia phenotype, supraventricular arrhythmias have also been described in catecholaminergic polymorphic ventricular tachycardia patients. The reason why ventricular myocytes exhibit stress-induced hyperactivity (ventricular ectopies and tachycardia) whereas sinoatrial node is often hypoactive (sinus bradycardia) remains elusive. Here, we explored for the first time [Ca 2+ ]i activity of sinoatrial node cells in intact tissues obtained from a mouse bearing the RyR2R4496C catecholaminergic polymorphic ventricular tachycardia mutation. Our results indicate that RyR2R4496C mice manifest a high incidence of sinoatrial node dysrhythmia (pauses) and an impaired positive chronotropic response to β-adrenergic stimulation. In RyR2R4496C sinoatrial node, there is an aberrant Ca 2+ homeostasis characterized by an increase in the diastolic Ca 2+ release at any time during the diastolic period. This almost continuous and low-grade Ca 2+ leakage unloads the sarcoplasmic reticulum, which in turn hampers action potential triggering and decreases the sinus rate. We provide here a mechanistic rationale for sinoatrial node dysfunction in catecholaminergic polymorphic ventricular tachycardia patients. Future work should focus on testing pharmacological approaches to treat dysfunction of heart automaticity using this novel ex vivo physiological preparation.
Conclusions:
The increased activity of RyR2R4496C in SAN leads to an unanticipated decrease in SAN automaticity by a Ca 2+ -dependent decrease of ICa,L and sarcoplasmic reticulum Ca 2+ depletion during diastole, identifying subcellular pathophysiological alterations contributing to the SAN dysfunction in catecholaminergic polymorphic ventricular tachycardia patients. 14 
Cardiomyocytes Derived From Pluripotent Stem Cells Recapitulate Electrophysiological Characteristics of an Overlap Syndrome of Cardiac Sodium Channel Disease
Summary: Clinical cardiology could benefit from greater insights into the pathology of cardiomyocytes in inherited cardiac disease. However, the availability of diseased cardiomyocytes is limited by the scarcity of biopsies from patients and the amount of tissue they yield. The advent of induced pluripotent stem cells, through which somatic cells can be genetically reprogrammed into stem cells able to differentiate to cardiomyocytes, now presents opportunities for solving this. However, a remaining issue is the extent to which the phenotype in these cells actually resembles that of cardiomyocytes in the heart itself. Here, we used reprogramming to investigate a cardiac overlap syndrome caused by a mutation in SCN5A, the sodium channel gene. Patients with this mutation (1795insD) can display symptoms of both long-QT syndrome type 3 and Brugada syndrome. We first derived induced pluripotent stem cells from mice with the corresponding SCN5A mutation. The derivative cardiomyocytes had electrophysiological properties similar to primary cardiomyocytes from the same heterozygous mutant mouse and from the embryonic stem cells used to generate it. The mutation resulted in a reduced Na+ current density (Brugada syndrome) and prolonged action potential (long-QT syndrome type 3), demonstrating that stem cell-derived cardiomyocytes could recapitulate the functional characteristics responsible for the observed multiple phenotypes. We then derived induced pluripotent stem cells from a patient with the SCN5A1795insD/+ mutation. The cardiomyocytes derived from these cells showed changes in the Na+ channel biophysical properties similar to those in the mouse cardiomyocytes, demonstrating that human induced pluripotent stem cells could also model the pathognomonic features of the overlap syndrome. This model offers new opportunities for identifying drug effectiveness and sensitivities of clinical relevance.
Conclusions: Here, we demonstrate that both embryonic stem celland iPSC-derived cardiomyocytes can recapitulate the characteristics of a combined gain-and loss-of-function Na + channel mutation and that the electrophysiological immaturity of PSC-derived cardiomyocytes does not preclude their use as an accurate model for cardiac Na + channel disease.
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Ranolazine Decreases Mechanosensitivity of the Voltage-Gated Sodium Ion Channel NaV1.5: A Novel Mechanism of Drug Action
Summary: The voltage-gated sodium-selective ion channel NaV1.5 is densely expressed in the myocardium and is responsible for the inward current during phase 0 of the action potential. NaV1.5 is also expressed in the gastrointestinal tract. NaV1.5 is mechanosensitive, with acute stretch being generally excitatory to this channel function. Mechanosensitivity may have clinical implications for disorders rooted in abnormal mechano-electric feedback, such as heart failure and atrial fibrillation. Ranolazine is a modulator of NaV1.5 function with multiple clinical effects but no definitive mechanism of action. This study demonstrates that ranolazine is an effective inhibitor of NaV1.5 mechanosensitivity at the whole cell and single channel level in both cardiac myocytes and cultured cells. We also provide some evidence on the mechanism of ranolazine inhibition of NaV1.5 mechanosensitivity. This effect does not require the established ranolazine binding site and appears to require bilayer partitioning. Inhibition of mechanosenstivity by ranolazine decreases excitability of NaV1.5 by mechanical stimuli and provides a new mechanism of drug action, with potential for applications in conditions of abnormal mechanoelectric feedback.
Conclusions: Ranolazine effectively inhibits mechanosensitivity of NaV1.5. The block of NaV1.5 mechanosensitivity by ranolazine does not utilize the established binding site and may require bilayer partitioning. Ranolazine block of NaV1.5 mechanosensitivity may be relevant in disorders of mechanoelectric dysfunction. In inborn or acquired atrioventricular block in small children, pacemaker electrodes traditionally were implanted into or sutured onto the right ventricle. This was suspected to cause dyssynchrony and heart failure. To determine optimal pacing electrode position, we performed a prospective study in minipigs with induced atrioventricular block comparing the effects of right ventricular free wall or left ventricular (LV) apex pacing (120 bpm) on LV hemodynamics, ultrastructure, and molecular remodeling. Right ventricular free wall pacing led to dyssynchrony and to more pronounced alterations in LV performance than LV apex pacing, whereas changes in calcium handling proteins, plasma catecholamines, and ultrastructure were unrelated to the location of ventricular pacing. LV stroke work, dP/dtmax, and dP/dtmin were reduced only in right ventricular free wall pacing. These data underline the importance of dyssynchrony for the development of LV dysfunction. Moreover, this study suggests LV apex pacing as the more suitable (better) pacing location and that avoidance of dyssynchrony is important in pacemaker implantation.
Conclusions:
The observed molecular remodeling seemed to be more dependent on heart rate than on dyssynchrony. LV apical pacing is associated with less dyssynchrony, a more physiological LV contraction pattern, and preserved LV function as opposed to RV free wall pacing.
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Prevalence and Prognostic Significance of T-Wave Inversions in Right Precordial Leads of a 12-Lead ECG in the Middle-Aged Subjects
Summary: T-wave inversion in right precordial leads V1 to V3 is a common finding in a 12-lead ECG of children and adolescents, and is sometimes present in healthy adults, as well. However, right precordial T-wave inversion can also be the first manifestation of a structural heart disease such as arrhythmogenic right ventricular cardiomyopathy. In the present study, we assessed the prevalence and prognostic significance of T-wave inversions in a large Finnish middle-aged general population cohort with a long follow-up. Inverted T waves in right precordial leads V1 to V3 were present in 0.5% of the subjects, but deeply inverted T waves (5 mm or more) or additional features suggestive of arrhythmogenic right ventricular cardiomyopathy were extremely rare. The prognosis associated with right precordial T-wave inversion was good and did not differ from the rest of the population. However, T-wave inversions in leads other than V1 to V3 were associated with a significantly increased risk of cardiac and arrhythmic death. Thus, although inverted T waves in V1 to V3 can raise a suspicion of a cardiomyopathy, in the absence of deeply inverted T waves or other features suggestive of a heart disease, this ECG pattern does not predict adverse outcome. In contrast, T-wave inversions in other than right precordial leads may reflect the presence of an underlying cardiac pathology and are associated with increased mortality.
Conclusions: T-wave inversions in right precordial leads are relatively rare in the general population, and are not associated with adverse outcome. Increased mortality risk associated with inverted T waves in other leads may reflect the presence of an underlying structural heart disease. 18 
Pacemaker Therapy in Patients With Neurally Mediated Syncope and Documented Asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): A Randomized Trial
Summary: We evaluated a treatment strategy based on early application of the implantable loop recorder in patients ≥40 years with a certain or highly likely diagnosis of neurally mediated syncope based on clinical evaluation. In our patients, therapy was delayed until documentation of a spontaneous prolonged (mean, 11 s) asystolic event was obtained by implantable loop recorder. In this highly selected population, which we estimated to be 9% of neurally mediated syncope patients referred for evaluation, cardiac-pacing therapy is effective in reducing syncopal recurrences. We found that ≈1 of 3 pacemaker patients will benefit from pacing therapy within the subsequent 2 years.
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Conclusions: Dual-chamber permanent pacing is effective in reducing recurrence of syncope in patients ≥40 years with severe asystolic neurally mediated syncope. The observed 32% absolute and 57% relative reduction in syncope recurrence support this invasive treatment for the relatively benign neurally mediated syncope.
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Duration of QRS Complex in Resting ECG Is a Predictor of Sudden Cardiac Death in Men
Summary: Sudden cardiac arrest accounts for one half of all deaths related to coronary heart disease and presents as the first manifestation of coronary heart disease in ≈20% to 30% of the deaths. Large epidemiological studies have not been able to identify specific ECG markers for sudden cardiac death (SCD), and little is known about the relationship between the duration of the QRS complex and the risk of SCD among the general population. Our study shows that prolonged QRS duration is an independent predictor of SCD, with risk levels comparable to those for established clinical risk factors such as smoking, lipids, hypertension, history of myocardial infarction or coronary heart disease, and type 2 diabetes mellitus. Each 10-ms increment in QRS duration was associated with a 27% higher SCD risk. Thus, the measurement of QRS duration may have utility in evaluation of SCD risk in the general population.
Conclusions: QRS duration is an independent predictor of the risk of SCD and may have utility in estimating SCD risk in the general population.
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Sudden Cardiac Arrest and Death Following Application of Shocks From a TASER Electronic Control Device
Summary: The safety of electronic control devices (ECDs) has been questioned. This article reports 8 cases of TASER X26 ECD-induced loss of consciousness in which first recorded rhythms were ventricular tachycardia/fibrillation in 6 and asystole (after ≈30 minutes of nonresponsiveness) in 1. An external defibrillator reported a shockable rhythm in 1 case, but no recording was made. From an analysis of the cases and data from animal and clinical ECD studies, it is the opinion of the author that ECD stimulation can cause cardiac electric capture and provoke cardiac arrest resulting from ventricular tachycardia/ventricular fibrillation. The cause is probably ventricular capture during the vulnerable period of the previous beat or ventricular capture at rates too fast for ventricular activation to remain organized. After prolonged ventricular tachycardia/ventricular fibrillation without resuscitation, asystole develops. The purpose of this article is not to condemn ECD use by trained professionals but to make ECD users aware that cardiac arrest caused by ventricular fibrillation can result from an ECD shock and to encourage users to be judicious concerning how and when to use the ECD weapon, to avoid chest shocks if possible, to monitor the person after an ECD shock, and to suspect this adverse response in any victim who loses consciousness. Users should be prepared to resuscitate, including deployment of an automated external defibrillator if indicated.
Conclusions: ECD stimulation can cause cardiac electric capture and provoke cardiac arrest resulting from ventricular tachycardia/ventricular fibrillation. After prolonged ventricular tachycardia/ventricular fibrillation without resuscitation, asystole develops.
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Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
Summary: Atrial fibrillation is a major cause of ischemic stroke.
Oral anticoagulants give good protection against ischemic stroke but also increase the risk of bleeding. Intracranial hemorrhage is the most feared complication with high mortality and morbidity. We investigated how to maximize the net clinical benefit by balancing ischemic stroke against intracranial hemorrhage in 182 678 atrial fibrillation patients in the Swedish National Hospital Discharge Register. Patients were classified according to stroke risk (CHADS2 and CHA2DS2-VASc) and bleeding risk (HAS-BLED [hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly, drugs/alcohol concomitantly]). As the risk of ischemic stroke increased, the risk of intracranial hemorrhage and other bleeding also increased. Patients with high bleeding risk scores suffered more ischemic strokes than bleeding events, so the net clinical benefit favored anticoagulation for almost all patients except those patients with very low embolic risk; the CHA2DS2-VASc was able to identify those patients (3.9% of all patients) who had no net clinical benefit or even some disadvantage from anticoagulant treatment with warfarin. Thus, we conclude that in almost all patients with atrial fibrillation, the risk of ischemic stroke without anticoagulant treatment is far higher than the risk of intracranial hemorrhage with anticoagulant treatment and that most atrial fibrillation patients should be offered effective thromboprophylaxis with oral anticoagulation.
Conclusions:
In almost all patients with atrial fibrillation, the risk of ischemic stroke without anticoagulant treatment is higher than the risk of intracranial bleeding with anticoagulant treatment. Analysis of the net benefit indicates that more patients may benefit from anticoagulant treatment.
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Risk of Arrhythmia and Sudden Death in Patients With Asymptomatic Preexcitation: A Meta-Analysis
Summary: The incidence of sudden cardiac death (SCD) and the management of this risk in patients with asymptomatic preexcitation remain controversial. We performed a meta-analysis of 20 studies reporting on asymptomatic patients (n=1869) with preexcitation who did not undergo ablation (11 722 person-years of follow-up). A total of 10 SCDs were reported with 9 SCDs from studies originating from Italy. The risk of SCD is estimated at 1.25 per 1000 personyears (95% confidence interval, 0.57-2.19). The risk of supraventricular tachycardia was 16 (95% confidence interval, 10-24) events per 1000 person-years of follow-up. The risk of SCD was statistically significantly lower in the non-Italian compared with the Italian studies (P=0.0044). Children had a numerically higher SCD event rate (P=0.07) and supraventricular tachycardia event rate (P=0.38) compared with adults. Therefore, a higher index of suspicion for arrhythmia is warranted, and careful follow-up with monitoring for arrhythmia in children seems prudent. When considering management options in patients with asymptomatic preexcitation, a carefully informed patient (or parent) needs to choose between the risk of SCD and the success and complication rates associated with electrophysiological study and ablation. The evolution of the clinical status from an asymptomatic state to symptoms likely portends a higher risk for SCD, and these patients should seek medical review.
Conclusions:
The low incidence of SCD and low risk of supraventricular tachycardia argue against routine invasive management in most asymptomatic patients with the Wolff-Parkinson-White ECG pattern. 2+ and membrane current/potentials in human atrial cardiomyocytes from sinus rhythm and AF patients. We found that AF is associated with enhanced diastolic Ca 2+ leak from the principal cellular Ca 2+ store, the sarcoplasmic reticulum, via malfunctioning sarcoplasmic reticulum ryanodine receptor (RyR2) channels. The leaked Ca 2+ was exchanged for Na + by an upregulated Na + -Ca 2+ exchanger, causing substantial depolarizing transient inward currents and increasing the susceptibility to cellular delayed afterdepolarizations/triggered activity. Pharmacological and biochemical studies showed that the primary mechanism for RyR2 dysfunction was hyperphosphorylation by upregulated Ca 2+ / calmodulin-dependent protein kinase-II. Protein kinase A, which can also cause RyR2 hyperphosphorylation, was found to play at most a secondary role. These findings add to our appreciation of the phenomenon of AF begets AF, indicating that, in addition to the well-established tendency of AF to promote its own persistence by remodeling the reentrant substrate, it can enhance spontaneous ectopic (triggered) activity, which induces reentry. Although the contribution of these cellular Ca
2+
-mediated proarrhythmic events to ectopic foci in AF patients in vivo remains to be confirmed, the concept of specifically targeting diastolic sarcoplasmic reticulum Ca 2+ leak mechanisms might open novel therapeutic avenues to prevent atrial arrhythmogenesis by normalizing cellular Ca 2+ handling.
Conclusions: Enhanced SR Ca 2+ leak through CaMKII-hyperphosphorylated RyR2, in combination with larger INCX for a given SR Ca 2+ release and increased diastolic [Ca 2+ ]i-voltage coupling gain, causes AF-promoting atrial delayed afterdepolarizations/triggered activity in cAF patients. Summary: It has remained controversial whether the concomitant maze procedure may improve long-term clinical outcomes in chronic atrial fibrillation patients who undergo mechanical heart valve replacement. In the present study, a retrospective analysis was carried out on 569 consecutive patients with atrial fibrillation-associated valvular heart disease who underwent mechanical valve replacement. Of them, 317 patients concomitantly underwent the maze procedure and 252 underwent mechanical valve replacement alone. After adjustment for differences in baseline risk profiles between the 2 groups of patients, patients who had undergone the maze procedure were at similar risks of death (hazard ratio, 1.15; 95% confidence interval, 0.65-2.03; P=0.63) but were at a significantly lower risk of thromboembolic events (hazard ratio, 0.29; 95% confidence interval, 0.12-0.73; P=0.008) compared with those who underwent valve replacement alone at a median follow-up of 63.6 months (range, 0.2-149.9 months). The effect of superior event-free survival by the concomitant maze procedure was notable in a low-risk EuroSCORE (0-3) subgroup (P=0.049), but it was insignificant in a high-risk EuroSCORE (≥4) subgroup (P=0.65). Furthermore, the combination of the maze procedure resulted in superior left ventricular (P<0.001) and tricuspid valvular functions (P<0.001) compared with valve replacement alone on echocardiographic assessments performed at a median of 52.7 months (range, 6.0-146.8 months) after surgery. These findings suggest that the combination of the maze procedure is a reasonable option for this population, especially for those with low risks of surgery. Further prospective, randomized studies are needed to confirm the findings of this study.
Conclusions:
Compared with valve replacement alone, the addition of the maze procedure was associated with a reduction in thromboembolic complications and improvements in hemodynamic performance in patients undergoing mechanical valve replacement, particularly in those with low risk of surgery. 25 
Conduction Remodeling in Human End-Stage Nonischemic Left Ventricular Cardiomyopathy
Summary: Ventricular arrhythmia is one of the primary causes of death in humans with heart failure. Despite major advances in the characterization of ionic and molecular remodeling that occurs during heart failure, the exact role of these changes in the formation of an electrophysiological substrate for arrhythmia and arrhythmogenesis itself are still poorly understood. Numerous animal models of heart failure have thus been developed to investigate the mechanisms of arrhythmogenesis. However, there exists insufficient electrophysiological data from human hearts because of the limited availability of live, human cardiac tissue for basic research in vitro. Our study provides an integrative investigation of arrhythmogenic substrate in endstage heart failure due to nonischemic cardiomyopathy in humans. We show for the first time in the same human hearts a relation among multiple levels of cardiac signaling: from protein expression and phosphorylation, protein-protein colocalization, to transmural conduction and repolarization. We present evidence that supports some previous animal and human findings at the cellular and molecular levels and contradicts some other findings in animal models. We show that conduction disorder is a critical component of arrhythmogenic substrate in patients with nonischemic cardiomyopathy. We demonstrate that conduction abnormalities lead to nonuniform propagation discontinuities and reentry conditioned by structural disorder. Moreover, we show that connexin 43 downregulation, dephosphorylation, and lateralization are likely causes of such conduction abnormalities. Thus, our findings highlight potential therapeutic targets for predicting and ameliorating the risk of sudden cardiac death in patients with heart failure.
Conclusions: Conduction disorder resulting from the anisotropic downregulation of Cx43 expression, the reduction of Cx43 phosphorylation, and increased fibrosis is likely to be a critical component of arrhythmogenic substrate in patients with nonischemic cardiomyopathy.
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Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy
Summary: Troponin I and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are widely available biomarker analyses for diagnosis and prognostication of cardiac diseases. We demonstrated that elevated levels of troponin I and NT-proBNP were common in patients with atrial fibrillation, with troponin elevations observed in 25% of the patients and NT-proBNP elevations in almost 75% of the patients. Elevated levels of any or both of these cardiac biomarkers provided incremental prognostic information to the currently used CHADS2 and CHA2DS2-VASc risk scores. Beyond clinical risk factors, an elevated level of troponin I or NT-proBNP identifies patients with a doubled risk for stroke or systemic embolism, and up to 6-fold increased risk of vascular death. Determination of troponin I or NT-proBNP may be used to improve risk prediction in patients with atrial fibrillation beyond currently used clinical risk scores.
Conclusions: Elevations of troponin I and NT-proBNP are common in patients with AF and independently related to increased risks of stroke and mortality. Cardiac biomarkers seem useful for improving risk prediction in AF beyond currently used clinical variables. use increased significantly in the overall study population and in black women, white women, black men, and white men. The increase in ICD use was greatest among blacks. In the GWTG-HF quality improvement program, a significant increase in ICD therapy use was observed over time in all 4 sex and race groups. The previously described racial disparities in ICD use were no longer present by the end of the study period; however, sex differences persisted.
Conclusions: In the GWTG-HF quality improvement program, a significant increase in ICD therapy use was observed over time in all sex and race groups. The previously described racial disparities in ICD use were no longer present by the end of the study period; however, sex differences persisted. Summary: Atrial fibrillation (AF) is the most common chronic arrhythmia in adults, and risk increases markedly with age. Experimental studies suggest that long-chain n-3 polyunsaturated fatty acids (n-3 PUFA) from seafood may reduce onset of AF, but most prior studies of n-3 PUFA and new-onset AF in ambulatory populations have used estimates based on dietary questionnaires and were not focused on older adults, the general population at highest risk. We prospectively investigated the associations of circulating blood levels of the n-3 PUFA eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with incidence of AF among 3,326 older men and women (≥65y) from 4 US communities over a 14-year period. We excluded study subjects taking fish oil supplements. After adjustment for other risk factors, participants in the top quartile of total n-3 PUFA (EPA+DPA+DHA) levels had 29% lower risk of AF, compared with the lowest quartile (P trend <0.004).
Among the individual n-3 fatty acids, only DHA was significantly associated with AF, with a 23% lower risk among participants in the highest versus lowest quartile (P=0.01). These associations were consistent among different subgroups, including men and women as well as whites and blacks. Although the observational nature of this study does not prove a causal relationship, these findings suggest that increased dietary intake of total n-3 PUFA or DHA from seafood may reduce incidence of AF in older adults.
Conclusions:
In older adults, higher circulating total long-chain n-3 PUFA and docosahexaenoic acid levels were associated with lower risk of incident AF. These results highlight the need to evaluate whether increased dietary intake of these fatty acids could be effective for the primary prevention of AF. Conclusions: There was a nonsignificant increase in MI with dabigatran compared with warfarin, but other myocardial ischemic events were not increased. Treatment effects of dabigatran were consistent in patients at higher and lower risk of myocardial ischemic events.
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Connexin43 Mutation Causes Heterogeneous Gap Junction Loss and Sudden Infant Death
Summary: Sudden infant death syndrome (SIDS) claims the lives of >2000 infants every year in the United States. By definition, SIDS is characterized by the unexplained death of an infant, but recent evidence has implicated mutations in genes associated with heritable arrhythmia syndromes in up to 10% to 15% of SIDS cases. GJA1 encodes the connexin43 (Cx43) protein, a crucial gap junction protein involved in the maintenance of synchronous ventricular contractions. Recently, genetic mosaicism in the GJA1 gene has been implicated in the pathogenesis of atrial fibrillation, and global and cardiac-specific Cx43 knockout mice display cardiac abnormalities and sudden death, making GJA1 a candidate gene for SIDS pathogenesis. In this study, we assessed the spectrum and prevalence of GJA1 genetic variation in nearly 300 SIDS victims and identified a missense mutation, E42K, in a 2-month-old white boy but not in either of his parents. This mutation localized to a key region of the Cx43 transmembrane domain and resulted in dominant-negative loss of cell-to-cell communication in vitro in the setting of preserved cellular trafficking. Immunohistochemical staining of the E42K-positive decedent's cardiac tissue demonstrated a mosaic staining pattern. This is the first study to implicate heterogeneous Cx43 loss in the pathogenesis of SIDS. This work also confirms previous studies arguing that it is the heterogeneous loss of Cx43, rather than uniform reduction in Cx43 levels, that creates an arrhythmogenic substrate by allowing dissipation and disruption of slow, safe conduction by sinks of well-coupled cells.
Conclusions: This study provides the first molecular and functional evidence implicating a GJA1 mutation as a novel pathogenic substrate for SIDS. E42K-connexin43 demonstrated a trafficking-independent reduction in junctional coupling in vitro and a mosaic pattern of mutational DNA distribution in deceased cardiac tissue, suggesting a novel mechanism of connexin43-associated sudden death.
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Brugada-Like Syndrome in Infancy Presenting With Rapid Ventricular Tachycardia and Intraventricular Conduction Delay
Summary: In clinical practice, the occurrence of rapid ventricular tachycardia in an infant is sufficiently uncommon that a comprehensive diagnostic evaluation usually ensues. This includes cardiac structural and functional assessment and metabolic, infectious disease, and toxicological analysis. In the absence of a clear etiology among these categorical entities (and perhaps even in the presence of drug-induced ventricular tachycardia), and, especially if the infant's ECG shows ventricular conduction delay while in sinus rhythm, a cardiac depolarizing channel defect should be considered. This diagnosis is supported by characteristic prolongation of the QRS duration during intravenous infusion of procainamide or by demonstration of a disease-causing gene mutation coding for a subunit of the cardiac L-type calcium channel (CACNB2) or the cardiac sodium channel (SCN5A). Making the diagnosis of what may be considered Brugada-like syndrome is of clinical importance for 2 reasons: reliable pharmacotherapy to prevent potentially fatal ventricular tachycardia recurrences has not yet been established; and infants may be especially vulnerable to such recurrences during febrile illnesses and following immunizations, both common events during infancy. Although medical therapy may be individualized based on response to drugs attempted during the initial event, antiarrhythmic drug use should be considered adjunctive therapy. Effective management strategies should include aggressive antipyretic therapy during febrile illnesses, prophylactic antipyretic drugs with immunizations, and perhaps inpatient telemetry associated with these events. Implantable cardioverter-defibrillator implantation may be life-saving once the infant is of sufficient size, acknowledging the high complication rate of device use in infancy.
Conclusions: Infants having rapid ventricular tachycardia and conduction abnormalities in the absence of structural or metabolic abnormalities are likely to have disease-causing mutations in cardiac depolarizing channels. 
